The
HEK293T (human embryonic kidney cell), CT26 (murine colon cancer),
RENCA (murine renal cell carcinoma), and A20 (murine lymphoma) cell lines were purchased from ATCC (Manassas, VA). The
HEK293T and CT26 cell lines were maintained in
DMEM (FUJIFILM Wako Pure Chemical Corporation, Osaka, Japan) supplemented with 10% foetal calf serum (FCS; Cytiva, Tokyo, Japan). The
RENCA and A20 cell lines were maintained in
RPMI medium (FUJIFILM Wako Pure Chemical Corporation) supplemented with 10% FCS. All tumour cells were confirmed to be
Mycoplasma (−) using a
PCR Mycoplasma Detection Kit (TaKaRa, Shiga, Japan) according to the manufacturer’s instructions before use.
Recombinant human Wnt3a protein was obtained from R&D (Minneapolis, MN).
Recombinant murine Wnt3a protein was purchased from PeproTech (Cranbury, NJ). Rat anti-mouse PD-1 mAb (RMP1-14) and control rat IgG2a mAb (RTK2758) were obtained from BioLegend (San Diego, CA).
Ishino T., Kawashima S., Tanji E., Ueno T., Ueda Y., Ogasawara S., Sato K., Mano H., Ishihara S., Kato N., Kawazu M, & Togashi Y. (2023). Somatic mutations can induce a noninflamed tumour microenvironment via their original gene functions, despite deriving neoantigens. British Journal of Cancer, 128(6), 1166-1175.